Fresenius Medical Care AG

37.9200.00Vol 35.90K1Y Perf 7.97%
Apr 16th, 2021 10:23 DELAYED
BID37.91 ASK37.94
Open37.80 Previous Close37.92
Pre-Market37.81 After-Market-
 -0.11 -0.29%  - -
Target Price
38.27 
Analyst Rating
Strong Buy 1.33
Potential %
1.14 
Finscreener Ranking
★★+     49.10
Insiders Trans % 3/6/12 mo.
-/-/- 
Value Ranking
★★★     52.58
Insiders Value % 3/6/12 mo.
-/-/- 
Growth Ranking
★★     46.26
Insiders Shares Cnt. % 3/6/12 mo.
-/-/- 
Income Ranking
★★+     43.28
Market Cap22.21B 
Earnings Rating
Strong Sell
Price Range Ratio 52W %
32.10 
Earnings Date
5th May 2021

Today's Price Range

37.8037.92

52W Range

33.8446.55

5 Year PE Ratio Range

8.4028.00

Summary:

Neutral

Technical Indicators: Neutral
Moving Averages: Buy
Performance
1 Week
0.85%
1 Month
4.06%
3 Months
-8.87%
6 Months
-9.61%
1 Year
7.97%
3 Years
-25.84%
5 Years
-13.92%
10 Years
7.81%

TickerPriceChg.Chg.%
FMS37.920.00000.00
AAPL134.45-0.0500-0.04
GOOG2 295.45-1.2100-0.05
MSFT260.120.62000.24
XOM56.60-0.3800-0.67
WFC42.950.71001.68
JNJ160.960.57000.36
FB307.05-0.7700-0.25
GE13.46-0.0900-0.66
JPM153.671.50000.99
Financial StrengthValueIndustryS&P 500US Markets
0.80
1.20
0.49
1.10
5.70
Leverage Ratio 2.80
ProfitabilityValueIndustryS&P 500US Markets
31.00
13.10
23.10
11.90
8.12
RevenueValueIndustryS&P 500US Markets
15.93B
27.19
1.67
2.05
DividendsValueIndustryS&P 500US Markets
1.88
0.72
10.91
11.64
Payout ratio26.00
Earnings HistoryEstimateReportedSurprise %
Q04 20200.700.768.57
Q03 20200.660.717.58
Q02 20200.540.6622.22
Q01 20200.620.52-16.13
Q04 20190.680.7510.29
Q03 20190.590.6713.56
Q02 20190.550.52-5.45
Q01 20190.520.5913.46
Earnings Per EndEstimateRevision %Trend
3/2021 QR0.45-32.84Negative
6/2021 QR0.53-26.39Negative
12/2021 FY2.28-25.49Negative
12/2022 FY2.59-15.64Negative
Next Report Date5th May 2021
Estimated EPS Next Report0.45
Estimates Count1
EPS Growth Next 5 Years %4.30
Volume Overview
Volume35.90K
Shares Outstanding585.67M
Trades Count308
Dollar Volume13.51M
Avg. Volume456.79K
Avg. Weekly Volume199.89K
Avg. Monthly Volume267.61K
Avg. Quarterly Volume458.29K

Fresenius Medical Care AG (NYSE: FMS) stock closed at 37.92 per share at the end of the most recent trading day (a 0.64% change compared to the prior day closing price) with a volume of 245.18K shares and market capitalization of 22.21B. Is a component of indices and it is traded on NYSE exchange. The company belongs in the Healthcare Providers & Services industry, Healthcare sector and employs 125364 people. Fresenius Medical Care AG CEO is Rice Powell.

The one-year performance of Fresenius Medical Care AG stock is 7.97%, while year-to-date (YTD) performance is -8.76%. FMS stock has a five-year performance of -13.92%. Its 52-week range is between 33.84 and 46.55, which gives FMS stock a 52-week price range ratio of 32.10%

Fresenius Medical Care AG currently has a PE ratio of 16.00, a price-to-book (PB) ratio of 1.65, a price-to-sale (PS) ratio of 1.40, a price to cashflow ratio of 4.40, a PEG ratio of 2.32, a ROA of 3.59%, a ROC of 6.45% and a ROE of 10.01%. The company’s profit margin is 8.12%, its EBITDA margin is 23.10%, and its revenue ttm is $15.93 Billion , which makes it $27.19 revenue per share.

Of the last four earnings reports from Fresenius Medical Care AG, there were 3 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $0.45 for the next earnings report. Fresenius Medical Care AG’s next earnings report date is 05th May 2021.

The consensus rating of Wall Street analysts for Fresenius Medical Care AG is Strong Buy (1.33), with a target price of $38.27, which is +1.14% compared to the current price. The earnings rating for Fresenius Medical Care AG stock is Strong Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Fresenius Medical Care AG has a dividend yield of 1.88% with a dividend per share of $0.72 and a payout ratio of 26.00%.

Fresenius Medical Care AG has a Neutral technical analysis rating based on Technical Indicators (ADX : 10.52, ATR14 : 0.79, CCI20 : 105.80, Chaikin Money Flow : 0.12, MACD : -0.11, Money Flow Index : 72.83, ROC : 1.17, RSI : 46.26, STOCH (14,3) : 81.33, STOCH RSI : 0.89, UO : 55.50, Williams %R : -18.67), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Fresenius Medical Care AG in the last 12-months were:

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
5 (83.33 %)
5 (83.33 %)
5 (83.33 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
1 (16.67 %)
1 (16.67 %)
1 (16.67 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.33
Strong Buy
1.33
Strong Buy
1.33

Fresenius Medical Care AG

Fresenius Medical Care is the largest dialysis company in the world, treating about 345,000 patients in roughly 4,000 clinics across the globe as of December 2019. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market and benefits from being the world's only fully integrated dialysis business. Services account for roughly 80% of firmwide revenue, including care coordination and ancillary operations, while products account for the other roughly 20%. Products typically enjoy a higher margin, making them a strong contributor to the bottom line.

CEO: Rice Powell

Telephone: +49 61726082522

Address: Else-Kroener-Strasse 1, Bad Homburg 61352, , DE

Number of employees: 125 364

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

0%100%

Bearish Bullish

75%25%

Bearish Bullish

54%46%

Bearish Bullish

63%38%

News

Stocktwits